Lind Global Fund III LP and Affiliates File Schedule 13G for Bionano Genomics, Inc.

Lind Global Fund III LP, Lind Global Partners III LLC, and Jeff Easton have filed a Schedule 13G with the SEC, disclosing their beneficial ownership of Bionano Genomics, Inc. common stock. The filing indicates that the Reporting Persons collectively own 9.9% of the company's common stock, including shares and warrants. The warrants are subject to a 9.9% beneficial ownership limitation. The filing is made pursuant to Rule 13d-1(c) and includes a Joint Filing Agreement among the Reporting Persons.